Summit Therapeutics (SMMT) Shares Outstanding (Entity) (2017 - 2026)

Summit Therapeutics (SMMT) Shares Outstanding (Entity) (2017 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 254.16 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 200.18 Mn
10 Summit Therapeutics 10.60 Bn 10.00 Bn - 776.02 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 776.02 Mn
Dec 31, 2025 775.37 Mn
Sep 30, 2025 744.44 Mn
Jun 30, 2025 742.81 Mn
Mar 31, 2025 741.61 Mn
Dec 31, 2024 737.63 Mn
Sep 30, 2024 737.09 Mn
Jun 30, 2024 724.32 Mn
Mar 31, 2024 701.97 Mn
Dec 31, 2023 701.66 Mn
Sep 30, 2023 697.85 Mn
Jun 30, 2023 697.69 Mn
Mar 31, 2023 378.16 Mn
Dec 31, 2022 211.09 Mn
Sep 30, 2022 148.58 Mn
Jun 30, 2022 98.12 Mn
Mar 31, 2022 98.12 Mn
Dec 31, 2021 98.04 Mn
Sep 30, 2021 97.63 Mn
Jun 30, 2021 97.35 Mn